ClinicalTrials.EU platform rolled out across Europe
September 25, 2024 09:14 ET
|
ClinicalTrials.EU
The European Clinical Trials Information Network (ClinicalTrials.EU) has today announced its official rollout across the continent.
Anti-retroviral Drugs Market to hit USD 42.5 billion by 2032, says Global Market Insights Inc.
September 25, 2024 06:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Anti-retroviral Drugs Market size will reach USD 42.5 billion by 2032. Growing awareness and early diagnosis of HIV will accelerate...
Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
September 24, 2024 07:30 ET
|
Wave Life Sciences USA, Inc.
Mean muscle content-adjusted dystrophin expression of 9.0% and unadjusted dystrophin of 5.5%, with high consistency across participants, in a prespecified analysis; dystrophin was comprised of two...
India Clinical Trials Market By Region, Competition, Forecast & Opportunities, 2020-2024 & 2024-2030
September 20, 2024 04:59 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "India Clinical Trials Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
September 19, 2024 08:00 ET
|
AIM ImmunoTech Inc.
Preliminary finding of stable disease in two out of three patients at 6 months in the first subject cohort Combination of Ampligen and Imfinzi continues to be generally well-tolerated with no...
Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
September 16, 2024 09:00 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
Virtual Clinical Trials Market Report 2024-2029 - Breaking Down Barriers in Women's Health Clinical Studies
September 16, 2024 08:37 ET
|
Research and Markets
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trials Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Virtual Clinical Trials...
BAMF Health Announces Strategic Clinical Trials Partnership with Adaptive Research
September 16, 2024 08:30 ET
|
Adaptive Research Inc
BAMF Health and Adaptive Research announced a strategic partnership to increase physician participation and patient enrollment in clinical trials.
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
September 16, 2024 08:00 ET
|
Science 37, Inc.
MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Today, Science 37, a leader in enhancing patient access to clinical trials, announced that it has received Frost & Sullivan’s 2024 Global...
Allarity Therapeutics Announces Two Patients Now Exceeding One Year of Treatment with Stenoparib in Advanced Ovarian Cancer Trial
September 16, 2024 08:00 ET
|
Allarity Therapeutics, Inc.
- Durable Clinical Benefit Observed Beyond a Year on Treatment in Heavily Pre-Treated Patients Boston (September 16, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR),...